⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

Imperial Brands IMB.L

United Kingdom Consumer Defensive
6.2/10
AI Analyst score
24.60 GBP
Last price at analysis date · analyst target 32.59 (+32.5%)
🛒 Where to buy IMB.LPartner brokers · UK (LSE) · sample 200.00 € orderUK (LSE)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold; the valuation is cheap but negative growth and regulatory risk limit upside potential.

Imperial Brands is a global tobacco company selling cigarettes, roll-your-own tobacco, and smoke-free nicotine products. Imperial Brands trades at a P/E of 11.55 and a FCF yield of 13.51%, reflecting an attractive valuation, but earnings growth is negative (-38.2%) and the sector faces structural decline.

Financial health
4.5
Quality / Moat
7.5
Valuation
8.5
Growth
2.6
Dividend
3.7
Momentum
2.0
Risk & Context
8.9

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E11.55
Fwd P/E6.69
EV/EBITDA7.64
P/B4.84
P/S0.95
PEG0.68
Market cap18.52 B GBP
Enterprise value30.68 B GBP
🏰 Quality and moat
ROIC (approx.)20.7%
Gross margin36.26%
FCF conversion62%
Operating margin16.03%
📈 Profitability and margins
ROE37.15%
ROA7.80%
Net margin8.96%
FCF2.50 B GBP
FCF yield13.51%
🏦 Solvency and liquidity
Total debt11.23 B GBP
Net debt10.73 B GBP
Cash497.0 M GBP
EBITDA4.02 B GBP
Net debt / EBITDA2.67
D/E243.80
Current ratio0.70
Quick ratio0.31
🚀 Growth
Revenue growth4.90%
Earnings growth-38.20%
EPS (TTM)2.13 GBP
EPS (Fwd)3.68 GBP
💰 Dividend and risk
Dividend yield0.07%
Payout75.4%
Beta0.13
Analyst consensusBuy (11)
Target price32.59 GBP
52-week range24.34 GBP – 36.32 GBP
⚠️ Main risk: The main risk is regulatory: increasing restrictions on tobacco and potential tax hikes that erode demand and margins.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

Imperial Brands is a global tobacco company selling cigarettes, roll-your-own tobacco, and smoke-free nicotine products. Imperial Brands trades at a P/E of 11.55 and a FCF yield of 13.51%, reflecting an attractive valuation, but earnings growth is negative (-38.2%) and the sector faces structural decline.

Score by category

CategoryScore
Financial health4.5
Quality / Moat7.5
Valuation8.5
Growth2.6
Dividend3.7
Momentum2.0
Risk & Context8.9

OVERALL SCORE: 6.2/10

Context and risks

Structural regulatory risk in the tobacco sector (advertising restrictions, plain packaging, excise taxes) directly impacts Imperial Brands' demand and margins.

News considered in the analysis

  • Imperial Brands cutting thousands of jobs in U.S. and Europe — El recorte de empleo es un plan de reestructuración de costes que, aunque busca eficiencia, indica presión sobre la demanda y puede acarrear costes de reestructuración a corto plazo.
  • Imperial Brands Touts Strong 2026 Start as NGP Growth and £320M Savings Plan Advance — El crecimiento en productos de próxima generación (NGP) y el plan de ahorro de £320M son positivos, pero el mercado ya lo descuenta parcialmente tras el anuncio.
  • Are Investors Undervaluing Imperial Tobacco Group (IMBBY) Right Now? — Titular de opinión de Zacks sin información nueva concreta.
  • Imperial Brands (LSE:IMB) Stock Sees Modest Fair Value Cut As Analysts Debate Upside — Recorte de valor razonable por parte de analistas, refleja una visión más cauta, pero es una revisión moderada.
  • AIR Global’s Best-in-Class 1H Performance Amid Disruptions, 2H Recovery – Quarterly Update Report — Informe de filial sobre desempeño resiliente en primera mitad, sugiere capacidad de gestión de disrupciones.

Verdict: Hold; the valuation is cheap but negative growth and regulatory risk limit upside potential.

Main risk: The main risk is regulatory: increasing restrictions on tobacco and potential tax hikes that erode demand and margins.

Other Consumer Defensive companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.